Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Overlap Syndrome

Overview


Plain-Language Overview

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Overlap Syndrome is a serious skin condition that affects the skin and mucous membranes, causing widespread redness, blistering, and peeling. It usually happens as a reaction to certain medications or infections. The condition damages the outer layer of the skin, leading to painful sores and making the body vulnerable to infections and fluid loss. It can also affect the eyes, mouth, and other organs, causing severe discomfort and complications. Because it involves a large area of skin, it requires urgent medical attention to prevent life-threatening problems.

Clinical Definition

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Overlap Syndrome is a severe mucocutaneous reaction characterized by widespread epidermal necrosis and detachment involving 10-30% of the body surface area, representing an intermediate severity between SJS (<10% BSA) and TEN (>30% BSA). It is primarily caused by a type IV hypersensitivity reaction to drugs such as anticonvulsants, sulfonamides, and allopurinol, or less commonly infections. The pathogenesis involves cytotoxic T-cell mediated apoptosis of keratinocytes leading to full-thickness epidermal necrosis. Clinically, it presents with fever, malaise, painful erythematous macules, targetoid lesions, and mucosal erosions. The condition is a dermatologic emergency due to risks of sepsis, fluid loss, and multi-organ failure. Early recognition and differentiation from other blistering disorders are critical for prognosis.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses


Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

Analytics Disclosure: If you allow analytics cookies, Doctogenic uses Google Analytics, Microsoft Application Insights, and Microsoft Clarity to understand site usage, diagnose issues, review heatmaps and session replay recordings, and improve the service on pages where those tools are enabled. Clarity is not enabled on account, purchase, billing, checkout, Stripe-related, or admin pages. You can change this choice through Cookie preferences.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.